Sun Group Wealth Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Sell
6,462
-244
-4% -$52.5K 1.11% 25
2026
Q1
$1.46M Buy
6,706
+37
+0.6% +$8.21K 1.15% 23
2025
Q4
$1.52M Buy
+6,669
New +$1.52M 1.22% 23

Other funds holding ABBV

Sun Group Wealth Partners's ABBV Position: Q2 2026 in Review

Sun Group Wealth Partners reduced its AbbVie (ABBV) stake by 3.6% in Q2 2026, selling an estimated $52.5K and leaving 6,462 shares worth $1.63M. The position accounts for 1.11% of the portfolio, ranked #25.

Sun Group Wealth Partners first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sun Group Wealth Partners held 6,462 shares of AbbVie worth $1.63M as of Q2 2026.
  • Sun Group Wealth Partners sold 244 AbbVie shares in Q2 2026, an estimated $52.5K.
  • AbbVie made up 1.11% of Sun Group Wealth Partners's portfolio in Q2 2026, its #25 holding.
  • Sun Group Wealth Partners first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sun Group Wealth Partners's 13F filing for Q2 2026, filed 23 Jul 2026.